Robert S Laitman MD
Geriatric Medicine, Behavioral Medicine, Nephrology
President of Team Daniel Running for Recovery from Serious Mental Illness
Join to View Full Profile
83 S Bedford Rdsuite 201Mount Kisco, NY 10549
Phone+1 914-864-2814
Fax+1 914-864-2826
Dr. Laitman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Robert Laitman is an Internal Medicine specialist based in Mount Kisco, NY, with subspecialties in Geriatric Medicine, Behavioral Medicine, and Nephrology. He graduated from Washington University in St. Louis School of Medicine in 1983 and completed his residency in Internal Medicine and fellowship in Nephrology at Albert Einstein College of Medicine-associated institutions. Dr. Laitman has authored multiple publications, including notable works on the use of clozapine and lupus nephritis. His research has been cited by other publications numerous times. He has received several honors, including the CMS Meaningful Use Stage 1 Certification and recognition as a Top Doctor in the New York Metro Area from Castle Connolly.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Nephrology, 1986 - 1987
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1983 - 1986
WashU MedicineClass of 1983
Certifications & Licensure
NY State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Amazing Charts, Amazing Charts, 2012, 2014-2015
- Top Doctors: New York Metro Area Castle Connolly, 2003-2014
- CMS Meaningful Use Stage 1 Certification Amazing Charts EHR, AmazingCharts, LLC, 2012-2013
Publications & Presentations
PubMed
- 15 citationsLetter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharma...Jose de Leon, Ross J Baldessarini, Richard Balon, John Bilbily, Stanley N Caroff
Journal of Clinical Psychopharmacology. 2025-04-09 - 19 citationsLetter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literatu...Jose de Leon, Ross J Baldessarini, Richard Balon, John Bilbily, Stanley N Caroff
Journal of Clinical Psychopharmacology. 2025-04-09 - 2 citationsThe EASE model for optimum use of clozapine: A clinician perspective.Robert S Laitman, Matcheri Keshavan, Ann C Mandel
Schizophrenia Research. 2023-11-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
